Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Asset Utilization Ratio (2016 - 2025)

Sunshine Biopharma's Asset Utilization Ratio history spans 9 years, with the latest figure at 1.18 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 2.5% year-over-year to 1.18; the TTM value through Dec 2025 reached 1.18, up 2.5%, while the annual FY2025 figure was 1.2, 0.59% down from the prior year.
  • Asset Utilization Ratio reached 1.18 in Q4 2025 per SBFM's latest filing, roughly flat from 1.18 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.21 in Q1 2025 to a low of 0.01 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 0.59, with a median of 0.63 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 85.06% in 2022, then skyrocketed 6027.84% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.1 in 2021, then grew by 27.67% to 0.12 in 2022, then surged by 606.75% to 0.88 in 2023, then soared by 31.33% to 1.15 in 2024, then grew by 2.5% to 1.18 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Asset Utilization Ratio are 1.18 (Q4 2025), 1.18 (Q3 2025), and 1.19 (Q2 2025).